R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
- PMID: 23210663
- PMCID: PMC3514105
- DOI: 10.1186/2162-3619-1-30
R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
Abstract
Background: The treatment strategy for gastric diffuse large cell lymphoma (DLBCL) has not been standardized in such as to the cycles of chemotherapy, dose of radiation, or necessity for the surgery. Although the results of CHOP or R-CHOP treatments have demonstrated the good prognosis, the treatments have been controversial in many cases.
Methods: We retrospectively analyzed 40 gastric DLBCL patients receiving chemotherapy with or without radiation in our institute. Those in stages II-IV were treated with six cycles of R-CHOP without radiation; for those in stage I, we administered three cycles of R-CHOP with radiation.
Results: The three-year overall survival (OS) and progression-free survival (PFS) rates were 95.2 and 91.8%, respectively. Those in stage I obtained 100% of OS. The radiation dose prescribed was 30.6 Gy for CR cases and 39.6 to 40 Gy for PR after chemotherapy. Although survival rates tended to correlate with staging groups or age-adjusted IPI classifications, multivariate statistical analysis did not show clear differences. All 14 patients with initial bleeding were successfully managed without surgery during treatment.
Conclusion: R-CHOP therapy was very effective for gastric DLBCL. It may be not necessary to use more than 30.6 Gy of radiotherapy in the highly chemo-sensitive cases. Less toxic treatments should be made available to gastric DLBCL patients.
Figures
Similar articles
-
[Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].Zhonghua Yi Xue Za Zhi. 2018 Jun 26;98(24):1945-1950. doi: 10.3760/cma.j.issn.0376-2491.2018.24.011. Zhonghua Yi Xue Za Zhi. 2018. PMID: 29996288 Chinese.
-
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.J Clin Oncol. 2010 Sep 20;28(27):4170-6. doi: 10.1200/JCO.2009.27.3441. Epub 2010 Aug 16. J Clin Oncol. 2010. PMID: 20713859
-
Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP.Cancer Med. 2019 Mar;8(3):982-989. doi: 10.1002/cam4.1982. Epub 2019 Feb 7. Cancer Med. 2019. PMID: 30730104 Free PMC article.
-
Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma.Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):91-8. doi: 10.1016/j.ijrobp.2014.12.042. Epub 2015 Feb 24. Int J Radiat Oncol Biol Phys. 2015. PMID: 25721091
-
[Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):234-241. doi: 10.3760/cma.j.cn112152-20190705-00413. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32252203 Chinese.
Cited by
-
Gastrointestinal lymphoma: the new mimic.BMJ Open Gastroenterol. 2019 Sep 13;6(1):e000320. doi: 10.1136/bmjgast-2019-000320. eCollection 2019. BMJ Open Gastroenterol. 2019. PMID: 31645987 Free PMC article. Review.
-
Synchronous diffuse large B-cell lymphoma of the stomach and small cell lung carcinoma: A case report.Medicine (Baltimore). 2017 Dec;96(50):e8873. doi: 10.1097/MD.0000000000008873. Medicine (Baltimore). 2017. PMID: 29390275 Free PMC article.
-
T-cell/histiocyte-rich large B-cell lymphoma of the thyroid.Exp Hematol Oncol. 2013 Jan 9;2(1):1. doi: 10.1186/2162-3619-2-1. Exp Hematol Oncol. 2013. PMID: 23298413 Free PMC article.
-
Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma.Cancer Cell Int. 2013 Jun 10;13:58. doi: 10.1186/1475-2867-13-58. eCollection 2013. Cancer Cell Int. 2013. PMID: 23758737 Free PMC article.
-
Primary Gastro-Intestinal Lymphoma and Gastro-Intestinal Adenocarcinoma: An Initial Study of CT Texture Analysis as Quantitative Biomarkers for Differentiation.Life (Basel). 2021 Mar 23;11(3):264. doi: 10.3390/life11030264. Life (Basel). 2021. PMID: 33806817 Free PMC article.
References
-
- Radman I, Kovacevic-Metelko J, Aurer I, Nemet D, Zupancic-Salek S, Bogdanic V, Sertic D, Mrsic M, Pulanic R, Gasparovic V. et al.Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study. Croat Med J. 2002;43(5):555–560. - PubMed
-
- Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C, Christian B, Lepage E, Tilly H, Morschhauser F. et al.Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2005;23(18):4117–4126. doi: 10.1200/JCO.2005.09.131. - DOI - PubMed
-
- Isobe K, Kawakami H, Tamaru J, Yasuda S, Uno T, Aruga T, Kawata T, Shigematsu N, Hatano K, Takagi T. et al.Consolidation radiotherapy following brief chemotherapy for localized diffuse large B-cell lymphoma: a prospective study. Leuk Lymphoma. 2003;44(9):1535–1539. doi: 10.1080/1042819031000097357. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials